Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05806554 · ClinicalTrials.gov registry record
Accuracy and Precision of the True Vie I3 Continuous Glucose Monitoring System: an Open Label, Multi-Center Trial
A clinical trial of Diabetes Mellitus, sponsored by Sinocare.
- Completed
- Registry status
- 159
- Enrollment target
- 6
- Study locations
NCT05806554 is a study of Diabetes Mellitus that has completed, run by Sinocare. The registered enrollment target is 159 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (91% lower). The trial reports 6 study locations across 5 states.
The verdict
NCT05806554, a study of Diabetes Mellitus, has completed, sponsored by Sinocare.
- COMPLETED
- Registry status
- 159 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of the investigation is to evaluate the performance of the I3 CGM according to the FDA's special controls for iCGM.
Conditions Studied
Interventions
- DEVICE Continuous glucose monitoring device
Study Locations (6)
Other
- PSHI Praxis GmbH - Mainz
- Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm - Ulm
Arkansas
- Woodland Research Northwest - Rogers
California
- Diablo Clinical Research - Walnut Creek
Georgia
- Atlanta Diabetes Associates - Atlanta
Washington
- Rainier Clinical Research Center - Renton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 159 participants |
| Start Date | 2023-07-19 |
| Est. Completion | 2024-10-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05806554
The ClinicalTrials.gov registry entry for NCT05806554 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 159 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (91% lower). The listed sponsor is Sinocare, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Continuous glucose monitoring device is the first listed.
NCT05806554 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Other, Arkansas, California.
Frequently Asked Questions
What is clinical trial NCT05806554 about?
NCT05806554 is a clinical study titled "Accuracy and Precision of the True Vie I3 Continuous Glucose Monitoring System: an Open Label, Multi-Center Trial". The purpose of the investigation is to evaluate the performance of the I3 CGM according to the FDA's special controls for iCGM.
What is the current status of trial NCT05806554?
This trial is currently completed. The enrollment target is 159 participants. The study started on 2023-07-19. Estimated completion is 2024-10-22.
What conditions does trial NCT05806554 study?
This clinical trial studies the following conditions: Diabetes Mellitus.
What interventions are being tested in trial NCT05806554?
The interventions under investigation include: Continuous glucose monitoring device (DEVICE).
Who is sponsoring clinical trial NCT05806554?
This trial is sponsored by Sinocare, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05806554 being conducted?
This trial has 6 study locations across Arkansas, California, Georgia, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Genetic Studies of Insulin and Diabetes
RECRUITING
-
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
RECRUITING · NA
-
Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
RECRUITING
-
Genetics Of Autoimmunity In Type I Diabetes
RECRUITING
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.